Bill Sponsor
House Bill 4460
116th Congress(2019-2020)
Turn the Tide Act
Introduced
Introduced
Introduced in House on Sep 24, 2019
Overview
Text
Introduced
Sep 24, 2019
Latest Action
Oct 28, 2019
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
4460
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Democrat
New Hampshire
Democrat
New Hampshire
House Votes (0)
Senate Votes (0)
No House votes have been held for this bill.
Summary

Turn the Tide Act

This bill funds through FY2023 the SUPPORT for Patients and Communities Act, which established various programs to address opioid addiction. Funded programs include (1) grants to increase access to substance use disorder treatments; (2) research, training, and developing best practices within the public health sector; (3) prevention and recovery services for youth, women, and infants; (4) overdose prevention and treatment; and (5) other community, judicial, and administrative programs. The bill also reauthorizes through FY2024 and increases funding for the Opioid State Targeted Response grants program and reauthorizes through FY2029 and increases funding for the Substance Abuse Prevention and Treatment Block Grant program.

Further, the bill prohibits health insurance plans, including Medicaid, from requiring prior authorization for medication-assisted treatment for opioid addiction. Plans also must cover at least one overdose-reversing drug without any cost-sharing requirement. The bill also revises Medicaid to require state payments to providers of mental and behavioral health services for substance use disorders and extends funding for demonstration projects that link provider payments to certain metrics. The bill also targets loan repayments for substance use disorder treatment professionals to states with the highest rates of drug overdoses.

Additionally, separate payment classifications must be established for specified procedures covered by Medicare that utilize non-opioid drugs to treat pain after surgery. The bill also (1) establishes grant programs to support responses to children exposed to trauma, (2) expands support for the drug-free communities program, and (3) funds peer-mentoring pilot programs for law enforcement agencies.

Text (1)
September 24, 2019
Actions (5)
10/28/2019
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
09/25/2019
Referred to the Subcommittee on Health.
09/24/2019
Referred to the Subcommittee on Health.
09/24/2019
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, the Judiciary, Oversight and Reform, Education and Labor, and Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
09/24/2019
Introduced in House
Public Record
Record Updated
Nov 1, 2022 1:49:52 PM